Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Accuracy of the "LLIFT", a Novel Non-invasive Biomarker for the Diagnosis of Non Alcoholic Fatty Liver (NAFL) and SteatoHepatitis (NASH) in a Population With High Risk of Metabolic Syndrome"

NCT04616664 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT04616664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04616664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Accuracy of the "LLIFT", a Novel Non-invasive Biomarker for the Diagnosis of Non Alcoholic Fatty Liver (NAFL) and SteatoHepatitis (NASH) in a Population With High Risk of Metabolic Syndrome"
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Completed
Start date
February 16, 2021
Completion date
January 17, 2024
Enrollment
158 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

nash - nonalcoholic steatohepatitis, obesity